Biovac has secured a $108.3 million financing package that will allow the South African pharma company to build the continent ...

In a blow to Bayer, a U.S. federal judge in Manhattan has said he will not block Johnson & Johnson’s survival claims on a key ...

Biogen and Minor League Baseball’s Durham Bulls are joining forces to celebrate “America 250” in the Triangle Community.  | ...

AbbVie is running a new psoriasis campaign based on feedback from real patients about how the condition affects their daily ...

Theramex has opted out of the U.K.’s self-regulatory program for pharma ma | Theramex has opted out of the U.K.’s ...

Following a quiet stretch, the legal back-and-forth over migraine meds from Teva and Eli Lilly has resurfaced, with Teva ...

Even as Eli Lilly gets underway with its next major obesity launch in Foundayo, an FDA document related to the oral treatment ...

Yet, the company has defied the odds, securing Filspari a landmark FDA approval in focal segmental glomerulosclerosis (FSGS) ...

Axplora leaders share how CDMO partnerships accelerate complex drug development and speed therapies to patients.

As biosimilar competition to Johnson & Johnson’s Stelara continues to chew off sales, the much-anticipated launch of the ...

As artificial intelligence continues to rewrite the rules in countless industries, pharma companies are increasingly getting ...

The FDA should strengthen the evidence required for the approval of drugs under its accelerated pathway and increase the ...